Joe, Author at JLM-BioCity

BiondVax Pharmaceuticals Universal Flu Vaccine Pivotal Phase 3 Study Results by End October

September 3, 2020September 3, 2020 Joe Biondvax, Biotech, JLM-BioCity, pharma

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ’s pivotal Phase 3 trial in Europe was completed in June 2020 and the analysis

← Previous

"...one of the best meetups organizations and very important source of information and connections for startups. ” - Tal Or

"Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads." - Alexander Naslednikov

Great atmosphere, great people. - Yael Ophir

There was an excellent networking atmosphere with impressive Panelists as well as high quality audience participants. I strongly recommend paying attention to future events. - Aviv Marom

The friendliest networking I have ever been to. Thanks for all the organizers for a productive and interesting evening. - Rafael Ezra

Very informative and eye-opening event. Thank you for the great hospitality. - Hemda Idel

Excellent event. Good speakers, interesting audience. Well done.- Gideon Silberman

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem! - Zeev Malyutin

Such an interesting lecture and great people attending! - Aurélie Schwarzbach

Interesting - I could see it helping people network - a good thing! - Jonathan Miller